---
title: "ProPhase Labs Q2 FY26 net loss narrows to $3 million; revenue falls to $1 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296397692.md"
description: "ProPhase Labs reported a Q2 FY26 GAAP net loss of $3 million, narrowing from prior periods. Revenue declined to $1 million due to lower supplement sales and no diagnostic revenue. Gross margin fell to 22.4% amid product mix variability. General and administrative expenses decreased to $2.9 million. Non-GAAP adjusted EBITDA improved to a loss of $561,000."
datetime: "2026-08-19T20:33:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296397692.md)
  - [en](https://longbridge.com/en/news/296397692.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296397692.md)
---

# ProPhase Labs Q2 FY26 net loss narrows to $3 million; revenue falls to $1 million

-   ProPhase Labs posted a GAAP net loss from continuing operations of USD 3 million, or USD 0.22 per share, for Q2 2026. \* Net revenue slipped to USD 1 million from USD 1.2 million a year earlier, on lower supplements sales; no diagnostic-services revenue. \* Gross margin narrowed to 22.4% from 58.9% in the year-ago quarter, reflecting consumer-products margin variability and product mix. \* General and administration expense fell to USD 2.9 million from USD 4.6 million, driven by lower personnel, overhead, and professional fees. \* Non-GAAP adjusted EBITDA from continuing operations improved to a loss of USD 561,000 from a loss of USD 807,000. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProPhase Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-039224), on August 19, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [PRPH.US](https://longbridge.com/en/quote/PRPH.US.md)

## Related News & Research

- [ProPhase Labs delays Q2 Form 10-Q filing as auditor review takes longer](https://longbridge.com/en/news/295973570.md)
- [ADM announces Q3 2026 distribution of R$ 0.22 per unit, payable Sept. 15](https://longbridge.com/en/news/296399586.md)
- [Kona BidCo raises Zalaris stake to 87.34% after buying 2,337 shares at NOK 100 apiece](https://longbridge.com/en/news/296256150.md)
- [Linde director Paula Rosput Reynolds reports purchase of 100 shares valued at $47,911.5](https://longbridge.com/en/news/296390825.md)
- [CIBC offers up to GBP 500,000 preference share-linked notes due 2031](https://longbridge.com/en/news/296433897.md)